Association of Reproductive Health Professionals
Association of Reproductive Health Professionals
Reproductive Health Topics Publications & Resources Professional Education Newsroom Membership Policy & Advocacy About Us
Medical Education Opportunities
Send To A Friend Send To A Friend Bookmark this Page Share this page
Webinars

Hormones and Healthy Bones



Related Links:


Hormones and Healthy Bones

Learning Objectives

At the conclusion of this activity, participants should be able to:

  • Identify two hormone-related conditions that affect bone health in your patients in order to inform an appropriate treatment plan
  • Critically evaluate three tools/tests used to accurately assess fracture risk in your patients
  • Use three interventions to support bone health, as measured by the absence of fractures in your patients
  • Apply pertinent recommendations for hormone therapy in your patients, so that quality of life is improved

Accreditation Information

Physicians:

Accreditation
The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation
ARHP designates this internet enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Pharmacists:The Association of Reproductive Health Professionals (ARHP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 1.0 contact hour of continuing education credit. The assigned universal program number for Hormones and Healthy Bones is 463-000-09-017-L04-P.

Others: A certificate of attendance will be issued indicating that this activity is accredited for 1 hour of AMA PRA Category 1 CreditTM.

Sponsoring Information

This program is sponsored by the Association of Reproductive Health Professionals.

Funding Information

This project is funded through an unrestricted educational grant from Wyeth Pharmaceuticals.

Disclosure Information

All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

Advisory Committee Disclosures

Robert Alan Adler, MD (Planner)
Hunter Holmes McGuire Veterans, Affairs Medical Center

Speaker for Novartis Corporation, Sanofi-Aventis LLC; Consultant for Merck and Co., Inc., and Eli Lilly and Company; Receives grants/research support from Novartis Corporation, Eli Lilly and Company, Procter and Gamble, and GlaxoSmithKline.

Douglas Bauer, MD (Planner)
University of California, San Francisco

Receives grants/research support from Amgen Inc., Novartis Corporation , and Merck and Co., Inc. 

Adrienne Berarducci, PhD, ARNP, BC (Planner)
University of South Florida, College of Nursing

Speaker for Sanofi-Aventis LLC, and Procter and Gamble; Receives grants/research support from Procter and Gamble.

Margaret L. Gourlay, MD, MPH (Planner)
University of North Carolina, Department of Family Medicine

Nothing to disclose

Cheryl Lambing, MD (Planner)
Ventura Co Med Center, Family Practice

Nothing to disclose

Michael Maricic, MD (Planner, Instructor)
Catalina Pointe Rheumatology

Speaker and consultant for Amgen Inc, Eli Lilly and Company, Novartis Corporation, F. Hoffmann-La Roche Ltd, and PTG; Receives grants/research support from Amgen Inc, Eli Lilly and Company, Novartis Corporation, F. Hoffmann-La Roche Ltd, and PTG.

Mary Beth O’Connell, PharmD, BCPS, FASHP, FCCP (Planner)
Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University

Speaker for F. Hoffmann-La Roche Ltd; Receives grants/research support from Merck and Co., Inc.

James A. Simon, MD, CCD, FACOG (Planner)
Clinical Professor, George Washington University
Consultant for Allergan Inc., Alliance for Better Bone Health, Ascend Therapeutics, Inc.,Barr Pharmaceuticals, Inc., Bayer AG, BioSante Pharmaceuticals , Concert Pharmaceuticals, Corcept Therapeutics Inc., Depomed Inc., GlaxoSmithKline, KV Pharmaceutical Company , Meditrina Pharmaceuticals, Inc. , Merck and Co., Inc., Merrion Pharmaceuticals , Nanma/Tripharma/Trinity, Novo Nordisk A/S, Novogyne Pharmaceuticals , Pear Tree Pharmaceuticals , QuatRx Pharmaceuticals Company , F. Hoffmann-La Roche Ltd, Sciele Pharma, Inc. , Solvay S.A. , Ther-Rx Corporation , Warner Chilcott, and Wyeth; Receives grants/research support from BioSante Pharmaceuticals ,  Boehringer Ingelheim GmbH , FemmePharma Global Healthcare, Inc. , GlaxoSmithKline, Nanma/Tripharma/Trinity, Novartis Corporation, Procter and Gamble; Speakers Bureau for Ascend Therapeutics, Inc., Barr Pharmaceuticals, Inc., Bayer AG, GlaxoSmithKline, KV Pharmaceutical Company , Merck and Co., Inc., Novartis Corporation, Novogyne Pharmaceuticals , Sciele Pharma, Inc., Ther-Rx Corporation , Warner Chilcott, and Wyeth.

ARHP Staff/Consultant Disclosures

Ellen Cohen, Cert Ed, Dip Ed

Director of Education

Nothing to disclose

Nancy Monson (Medical Writer)

Consultant (Expert Medical Writer)

Nothing to disclose

Beth Jordan, MD

Medical Director

Nothing to disclose

Amy Swann, MA

VP of Operations

Nothing to disclose

Wayne Shields

President and CEO

Nothing to disclose

Allison Tombros Korman, MHS

Associate Director of Education

Nothing to disclose

 



Back